Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Jose M. Feola"'
Autor:
Jose M. Feola, J. Yoneda, Holly H. Gallion, Yosh Maruyama, Paul D. DePriest, J.R. van Nagell, Jacek Wierzbicki
Publikováno v:
American Journal of Clinical Oncology. 16:168-174
The objective of this study was to review severe complication frequency in a protocol study using a defined prescribed dose combined with fractionated whole pelvis radiotherapy to 40-45 Gy. The method used a dose of Cf neutrons to 35 Gy equivalents (
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:61-67
Regeneration of clonogens in human cervical cancer was assessed by the pathological evaluation of the hysterectomy specimen after intracavitary 252Cf neutron brachytherapy implants separated by varying time intervals followed by extrafascial hysterec
Autor:
Jose M. Feola, Jacek Wierzbicki, Yosh Maruyama, J.R. van Nagell, Deborah E. Powell, J. Yoneda
Publikováno v:
The British Journal of Radiology. 63:270-277
Clinical data of the University of Kentucky trial using californium (252Cf), or caesium (137Cs), are reviewed for dose–response based on the endpoint of tumour eradication estimated from hysterectomy specimens obtained 4–6 weeks after preoperativ
Publikováno v:
International journal of radiation oncology, biology, physics. 27(4)
Purpose: Data for the 30 day bone marrow syndrome (BM-50) and the 6–10 day gastrointestinal (GI-50) syndrome for a one and two fraction schedule and acute and low dose rate irradiation using pure and mixed Cf-252 and photon radiation are presented.
Publikováno v:
Advances in Neutron Capture Therapy ISBN: 9781461362968
The use of broad beams of thennal/epithermal neutrons £rpm reactors or accelerators used in conjunction with chemical agents containing Boron-10 (10 B) or Gadolinium-157 has been postulated to allow selective therapy in tumor and the target volume.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eddb69f8ed63df04984b0d368328e85
https://doi.org/10.1007/978-1-4615-2978-1_27
https://doi.org/10.1007/978-1-4615-2978-1_27
Autor:
Khalid Z. Matalka, Rolf F. Barth, Yosh Maruyama, Jacek Wierzbicki, Jose M. Feola, Michael Q. Bailey
Publikováno v:
Advances in Neutron Capture Therapy ISBN: 9781461362968
Californium-252 brachytherapy has been used clinically to treat bulky localized tumors such as cervical carcinomas and glioblastoma multiforme1,2. Results from the initial therapy trials have been promising, and have stimulated others to consider thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e53ea32f1ebe1be795b8963c1fc13b2a
https://doi.org/10.1007/978-1-4615-2978-1_107
https://doi.org/10.1007/978-1-4615-2978-1_107
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:1104-1105
Autor:
Kevin G. Wilson, Yosh Maruyama, Jose M. Feola, Robert J. Yaes, Muneyasu Urano, Robert C. Miller
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:213
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 9:1715-1721
Reports on clinical study of Cf-252 pelvic brachytherapy are reviewed and show that complication frequency is low. Low dose rate (LDR) neutron brachytherapy has been shown to be effective against cervical and advanced pelvic cancers; and produces 5 y